AXM Pharma

AXM Pharma was a specialty pharmaceutical company that primarily operated in the People's Republic of China through its wholly-owned subsidiary, AXM Pharma (Shenyang) Co., Ltd. The company focused on the development, manufacturing, and marketing of generic and over-the-counter (OTC) drugs, including antibiotics, analgesics, and vitamins. AXM Pharma operated a large-scale, GMP-certified manufacturing facility in Shenyang to capitalize on the expanding Chinese healthcare market. During its peak, the company was listed on the American Stock Exchange under the symbol AXJ. However, AXM Pharma faced significant financial and regulatory challenges, leading to its delisting in 2008. The company is currently inactive and no longer maintains active pharmaceutical operations.